T Lymphocyte-Captured DNA Network for Localized Immunotherapy

J Am Chem Soc. 2021 Nov 24;143(46):19330-19340. doi: 10.1021/jacs.1c07036. Epub 2021 Nov 15.

Abstract

The efficient isolation of immune cells with high purity and low cell damage is important for immunotherapy and remains highly challenging. We herein report a cell capture DNA network containing polyvalent multimodules for the specific isolation and in situ incubation of T lymphocytes (T-cells). Two ultralong DNA chains synthesized by an enzymatic amplification process were rationally designed to include functional multimodules as cell anchors and immune adjuvants. Mutually complementary sequences facilitated the formation of a DNA network and encapsulation of T-cells, as well as offering cutting sites of a restriction enzyme for the responsive release of T-cells and immune adjuvants. The purity of captured tumor-infiltrating T-cells reached 98%, and the viability of T-cells maintained ∼90%. The T-cells-containing DNA network was further administrated to a tumor lesion for localized immunotherapy. Our work provides a robust nanobiotechnology for efficient isolation of immune cells and other biological particles.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • DNA / immunology*
  • Immunotherapy*
  • Melanoma / immunology*
  • Mice
  • Mice, Inbred C57BL
  • T-Lymphocytes / immunology*

Substances

  • DNA